BCDA - BioCardia, Inc.
1.18
-0.025 -2.119%
Share volume: 104,208
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$1.20
-0.03
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-13-2024 | 03-26-2025 | 05-14-2025 | 08-11-2025 | 11-12-2025 | |
| Assets | ||||||||
| Total Assets | 2.679 M | 2.890 M | 6.267 M | 3.724 M | 2.166 M | 2.089 M | 6.148 M | |
| Current Assets | 1.259 M | 1.573 M | 5.056 M | 2.622 M | 1.173 M | 1.199 M | 5.365 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 949.000 K | 1.421 M | 4.930 M | 2.371 M | 949.000 K | 980.000 K | 5.287 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 75.000 K | 61.000 K | 47.000 K | 33.000 K | 21.000 K | 17.000 K | 13.000 K | |
| Other Assets | 1.345 M | 1.256 M | 1.164 M | 1.069 M | 972.000 K | 873.000 K | 770.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 2.679 M | 2.890 M | 6.267 M | 3.724 M | 2.166 M | 2.089 M | 6.148 M | |
| Total liabilities | 4.954 M | 4.851 M | 3.514 M | 2.887 M | 3.686 M | 3.975 M | 3.521 M | |
| Total current liabilities | 4.071 M | 4.071 M | 2.840 M | 2.321 M | 3.234 M | 3.642 M | 3.310 M | |
| Accounts Payable | 1.030 M | 1.447 M | 569.000 K | 385.000 K | 818.000 K | 1.233 M | 1.080 M | |
| Other liabilities | 883.000 K | 780.000 K | 674.000 K | 566.000 K | 452.000 K | 333.000 K | 211.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 883.000 K | 780.000 K | 674.000 K | 566.000 K | 452.000 K | 333.000 K | 211.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -2.275 M | -1.961 M | 2.753 M | 837.000 K | -1.520 M | -1.886 M | 2.627 M | |
| Common stock | 152.167 M | 154.127 M | 160.578 M | 160.958 M | 161.313 M | 162.996 M | 168.992 M | |
| Retained earnings | -154.442 M | -156.088 M | -157.825 M | -160.121 M | -162.833 M | -164.882 M | -166.365 M |